vs
CRYO CELL INTERNATIONAL INC（CCEL）与Rocky Mountain Chocolate Factory, Inc.（RMCF）财务数据对比。点击上方公司名可切换其他公司
CRYO CELL INTERNATIONAL INC的季度营收约是Rocky Mountain Chocolate Factory, Inc.的1.0倍（$7.8M vs $7.5M），Rocky Mountain Chocolate Factory, Inc.净利率更高（-2.1% vs -48.7%，领先46.6%），CRYO CELL INTERNATIONAL INC同比增速更快（-2.3% vs -4.4%），CRYO CELL INTERNATIONAL INC自由现金流更多（$1.2M vs $-1.3M），过去两年Rocky Mountain Chocolate Factory, Inc.的营收复合增速更高（1.9% vs -0.1%）
Cryo-Cell国际是一家脐带血库企业，由丹·理查德于1989年创立，是全球首家分离并储存干细胞的民营脐带血库，总部位于佛罗里达州奥兹马尔，地处坦帕市郊。
落基山巧克力厂是美国知名巧克力企业，同时开展国际特许经营业务，集糖果生产与零售运营于一体，总部位于美国科罗拉多州杜兰戈，除美国本土门店外，在巴拿马、菲律宾也设有经营网点。
CCEL vs RMCF — 直观对比
营收规模更大
CCEL
是对方的1.0倍
$7.5M
营收增速更快
CCEL
高出2.2%
-4.4%
净利率更高
RMCF
高出46.6%
-48.7%
自由现金流更多
CCEL
多$2.5M
$-1.3M
两年增速更快
RMCF
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $7.8M | $7.5M |
| 净利润 | $-3.8M | $-155.0K |
| 毛利率 | 77.9% | 34.0% |
| 营业利润率 | -50.6% | 1.1% |
| 净利率 | -48.7% | -2.1% |
| 营收同比 | -2.3% | -4.4% |
| 净利润同比 | -105.1% | 81.7% |
| 每股收益（稀释后） | $-0.46 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCELRMCF
| Q4 25 | $7.8M | $7.5M | ||
| Q3 25 | $7.8M | $6.8M | ||
| Q2 25 | $7.9M | $6.4M | ||
| Q1 25 | $8.0M | $8.9M | ||
| Q4 24 | $8.0M | $7.9M | ||
| Q3 24 | $8.1M | $6.4M | ||
| Q2 24 | $8.0M | $6.4M | ||
| Q1 24 | $7.9M | $7.3M |
净利润CCELRMCF
| Q4 25 | $-3.8M | $-155.0K | ||
| Q3 25 | $749.4K | $-662.0K | ||
| Q2 25 | $355.8K | $-324.0K | ||
| Q1 25 | $282.9K | $-2.9M | ||
| Q4 24 | $-1.9M | $-847.0K | ||
| Q3 24 | $1.1M | $-722.0K | ||
| Q2 24 | $655.8K | $-1.7M | ||
| Q1 24 | $556.2K | $-1.6M |
毛利率CCELRMCF
| Q4 25 | 77.9% | 34.0% | ||
| Q3 25 | 77.0% | 23.6% | ||
| Q2 25 | 76.6% | 31.1% | ||
| Q1 25 | 75.1% | 10.8% | ||
| Q4 24 | 78.4% | 23.4% | ||
| Q3 24 | 73.6% | 31.8% | ||
| Q2 24 | 74.8% | 12.8% | ||
| Q1 24 | 73.7% | 24.3% |
营业利润率CCELRMCF
| Q4 25 | -50.6% | 1.1% | ||
| Q3 25 | 24.3% | -7.0% | ||
| Q2 25 | 18.8% | -2.3% | ||
| Q1 25 | 13.3% | -30.3% | ||
| Q4 24 | -1.5% | -8.9% | ||
| Q3 24 | 17.2% | -14.3% | ||
| Q2 24 | 17.3% | -25.4% | ||
| Q1 24 | 10.5% | -21.7% |
净利率CCELRMCF
| Q4 25 | -48.7% | -2.1% | ||
| Q3 25 | 9.6% | -9.7% | ||
| Q2 25 | 4.5% | -5.1% | ||
| Q1 25 | 3.5% | -32.5% | ||
| Q4 24 | -23.2% | -10.7% | ||
| Q3 24 | 13.0% | -11.3% | ||
| Q2 24 | 8.2% | -25.9% | ||
| Q1 24 | 7.1% | -21.9% |
每股收益（稀释后）CCELRMCF
| Q4 25 | $-0.46 | $-0.02 | ||
| Q3 25 | $0.09 | $-0.09 | ||
| Q2 25 | $0.04 | $-0.04 | ||
| Q1 25 | $0.03 | $-0.38 | ||
| Q4 24 | $-0.23 | $-0.11 | ||
| Q3 24 | $0.13 | $-0.11 | ||
| Q2 24 | $0.08 | $-0.26 | ||
| Q1 24 | $0.07 | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.3M | $641.0K |
| 总债务越低越好 | $8.4M | — |
| 股东权益账面价值 | $-18.6M | $6.0M |
| 总资产 | $61.7M | $20.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CCELRMCF
| Q4 25 | $3.3M | $641.0K | ||
| Q3 25 | $3.2M | $2.0M | ||
| Q2 25 | $4.4M | $893.0K | ||
| Q1 25 | $3.5M | $720.0K | ||
| Q4 24 | $3.5M | $1.1M | ||
| Q3 24 | $2.1M | $973.0K | ||
| Q2 24 | $1.5M | $637.0K | ||
| Q1 24 | $979.6K | $2.1M |
总债务CCELRMCF
| Q4 25 | $8.4M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $8.4M | — | ||
| Q1 25 | $8.5M | — | ||
| Q4 24 | $8.5M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.6M | — |
股东权益CCELRMCF
| Q4 25 | $-18.6M | $6.0M | ||
| Q3 25 | $-14.8M | $6.1M | ||
| Q2 25 | $-15.6M | $6.7M | ||
| Q1 25 | $-14.7M | $7.0M | ||
| Q4 24 | $-13.2M | $9.8M | ||
| Q3 24 | $-9.6M | $10.5M | ||
| Q2 24 | $-10.7M | $9.0M | ||
| Q1 24 | $-10.3M | $10.6M |
总资产CCELRMCF
| Q4 25 | $61.7M | $20.7M | ||
| Q3 25 | $63.2M | $22.3M | ||
| Q2 25 | $64.4M | $20.1M | ||
| Q1 25 | $64.4M | $21.2M | ||
| Q4 24 | $64.7M | $21.6M | ||
| Q3 24 | $62.9M | $21.1M | ||
| Q2 24 | $62.6M | $19.0M | ||
| Q1 24 | $61.7M | $20.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3M | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | $1.2M | $-1.3M |
| 自由现金流率自由现金流/营收 | 15.5% | -16.9% |
| 资本支出强度资本支出/营收 | 0.9% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $5.2M | — |
8季度趋势，按日历期对齐
经营现金流CCELRMCF
| Q4 25 | $1.3M | $-1.2M | ||
| Q3 25 | $2.5M | $-488.0K | ||
| Q2 25 | $707.0K | $350.0K | ||
| Q1 25 | $954.1K | $1.2M | ||
| Q4 24 | $2.2M | $-2.1M | ||
| Q3 24 | $2.4M | $-3.5M | ||
| Q2 24 | $1.8M | $-2.2M | ||
| Q1 24 | $-356.9K | $129.0K |
自由现金流CCELRMCF
| Q4 25 | $1.2M | $-1.3M | ||
| Q3 25 | $2.5M | $-544.0K | ||
| Q2 25 | $644.6K | $182.0K | ||
| Q1 25 | $892.0K | — | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $2.3M | $-4.6M | ||
| Q2 24 | $21.5K | $-2.6M | ||
| Q1 24 | $-814.6K | $-352.3K |
自由现金流率CCELRMCF
| Q4 25 | 15.5% | -16.9% | ||
| Q3 25 | 31.9% | -8.0% | ||
| Q2 25 | 8.1% | 2.9% | ||
| Q1 25 | 11.2% | — | ||
| Q4 24 | 26.8% | — | ||
| Q3 24 | 27.9% | -72.6% | ||
| Q2 24 | 0.3% | -40.2% | ||
| Q1 24 | -10.4% | -4.9% |
资本支出强度CCELRMCF
| Q4 25 | 0.9% | 0.5% | ||
| Q3 25 | 0.5% | 0.8% | ||
| Q2 25 | 0.8% | 2.6% | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 2.3% | 17.5% | ||
| Q2 24 | 21.8% | 6.5% | ||
| Q1 24 | 5.8% | 6.6% |
现金转化率CCELRMCF
| Q4 25 | — | — | ||
| Q3 25 | 3.38× | — | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 3.37× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.32× | — | ||
| Q2 24 | 2.70× | — | ||
| Q1 24 | -0.64× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCEL
暂无分部数据
RMCF
| Manufacturing | $5.9M | 78% |
| Transferred At Point In Time | $1.2M | 16% |
| Other | $414.0K | 5% |
